GLIOMAS
Clinical trials for GLIOMAS explained in plain language.
Never miss a new study
Get alerted when new GLIOMAS trials appear
Sign up with your email to follow new studies for GLIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can this drug reach the brain? new trial aims to find out
Disease control Recruiting nowThis early-phase trial tests whether the drug ulixertinib can cross the blood-brain barrier in people with recurrent brain tumors called gliomas. About 40 adults will receive the drug before surgery to see how well it reaches the tumor and to check for side effects. The goal is t…
Matched conditions: GLIOMAS
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:11 UTC
-
AI reads brain scans to spot tumors without a needle
Diagnosis Recruiting nowThis study will collect MRI scans from 3000 adults with brain tumors (like gliomas or metastases) to train an AI system. The goal is to help doctors identify tumor types more accurately without surgery. If successful, it could reduce the number of biopsies needed.
Matched conditions: GLIOMAS
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated May 14, 2026 12:01 UTC
-
New lab test aims to match brain tumor patients with best drugs
Knowledge-focused Recruiting nowThis study is testing a new technology called SmartMatch that checks how a person's brain tumor tissue reacts to different drugs. The goal is to see if the test can give results within 21 days after surgery. About 80 people aged 15 and older with recurrent brain tumors who are al…
Matched conditions: GLIOMAS
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC